By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adocia 

115 avenue Lacassagne

Lyon    69003  France
Phone: +33-(0)4-72-610-610 Fax: +33-(0)4-72-363-967


SEARCH JOBS

Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins. Adocia’s insulin formulation portfolio, featuring four clinical-stage products and one preclinical product, is among the largest and most differentiated in the industry.

YEAR FOUNDED:

December 2005

LEADERSHIP:

Founders: Gérard Soula, Olivier Soula, and Rémi Soula

CEO: Gérard Soula

CFO: Valérie Danaguezian

JOBS:

Please click here for Adocia job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Private

Web Site: Adocia
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Biotechnology





Company News
Adocia Receives The 1st Prize For "Profitable Growth" And The 3rd "Technology Fast 50" Prize As Part Of The 2016 Deloitte In Extenso Technology Fast 50 Grand Rhône Alpes 11/8/2016 9:37:58 AM
Adocia Announces Positive Topline Results From A Phase 1b Clinical Trial Measuring The Post-Meal Effect Of Rapid-Acting Human Insulin, Hinsbet U100 10/31/2016 3:17:58 PM
Adocia Announces Third Quarter 2016 Financial Results 10/13/2016 9:23:29 AM
Adocia Received The EY Global Company Award For The Auvergne Rhône-Alpes Region 9/22/2016 11:22:11 AM
Adocia Announces New BioChaperone Program Combining A Basal Insulin And GLP-1s 9/14/2016 9:19:39 AM
Adocia To Present Clinical Data Validating BioChaperone Technology At The 2016 EASD Annual Meeting 9/8/2016 12:59:52 PM
Adocia Announces New BioChaperone Program Combining A Basal Insulin And GLP-1s 9/7/2016 2:30:00 PM
Adocia's Foot Ulcer Med Flunks Phase III Test 8/26/2016 6:48:25 AM
Adocia Reinforces Its Focus On Diabetes With The Launch Of A New Project: BioChaperone Glucagon 6/8/2016 1:01:05 PM
Adocia To Present Data Validating The Potential Of Biochaperone Technology At The American Diabetes Association 76th Scientific Sessions 6/6/2016 4:19:45 PM
1234567
//-->